Under construction – not a live service
Sign in
Not yet taking people in TaiwanNo phase

Magnetic brain stimulation for thinking skills in mild memory decline or early Alzheimer disease

Tests magnetic brain stimulation on thinking skills in people with early memory loss.

Plain-language title generated from the registry record
Registry title: iTBS in MCI and Mild AD

Key facts

Where
Taipei, TaiwanSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 50 and 85 years old?

Source: NCT06670820, who can take part

Where in Taiwan

  • Tri-Service General HospitalTaipei, TaiwanNo longer taking part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
National Defense Medical Center, Taiwan
Trial code
NCT06670820
Record updated
1 November 2024
Original description
This study aims to examine the effects of iTBS on cognitive function in individuals with MCI or mild AD, with a secondary objective of exploring prefrontal TBS mechanisms for cognitive function and the effect of iTBS on BDNF.Read full original descriptionShow less

The Effects of Intermittent Theta-burst Stimulation on Cognitive Function in Patients With Mild Cognitive Impairment and Mild Alzheimer's Disease and the Role of Brain-Derived Neurotrophic Factor

This study aims to examine the effects of iTBS on cognitive function in individuals with MCI or mild AD, with a secondary objective of exploring prefrontal TBS mechanisms for cognitive function and the effect of iTBS on BDNF.

Inclusion: Clinical diagnosis of MCI (overall Clinical Dementia Rating of 0.5); Clinical diagnosis of mild Alzheimer's Disease (overall Clinical Dementia Rating of 0.5 or 1).

Exclusion: Drug abuse; History of stroke; History of uncontrol seizure; History of significant head trauma followed by persistent neurologic deficit or known structural brain abnormality; Mental illness.

ClinicalTrials.gov NCT06670820